Latest Breaking News On - Charlotte spitz - Page 4 : comparemela.com

Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases

Resalis Therapeutics today announced its completion of the seed financing round of €10 million to establish a non-coding RNA (ncRNA)-based therapeutic approach for the treatment of metabolic diseases.

Dennis riedlAlessandro tonioloRiccardo panellaPietro puglisiSakari kauppinenCharlotte spitzAalborg universityTrophic communicationsResalis therapeuticsClaris venturesItalian angelsManaging partnerResali board

Ethris GmbH: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses

Ethris to contribute its second-generation mRNA and Lipidoid Nanoparticle (LNP) stabilisation formulation technologies DIOSynVax to contribute its novel computational design-based multi-virus

Kostenloser wertpapierhandelEthris gmbMelanie savilleCarsten rudolphJonathan heeneyCharlotte spitzTrophic communicationsCoalition for epidemic preparedness innovationsLipidoid nanoparticleEpidemic preparedness innovationsUnited kingdom basedSevere acute respiratory syndromeMiddle east respiratory syndromeExecutive director

Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses

Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ethris gmbMelanie savilleCarsten rudolphJonathan heeneyCharlotte spitzTrophic communicationsCoalition for epidemic preparedness innovationsLipidoid nanoparticleEpidemic preparedness innovationsUnited kingdom basedSevere acute respiratory syndromeMiddle east respiratory syndromeExecutive director

Cardior Pharmaceuticals: Cardior Appoints Dr Russell Greig as Independent Chairman of the Board

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Dr. Russell Greig

United kingdomRussell greigClaudia ulbrichKostenloser wertpapierhandelClaudia ulbrich barbara gaertner rupprechtMarkus hosangRussellg greigCharlotte spitzCardior pharmaceuticals gmbUniversity of manchesterTrophic communicationsCardior pharmaceuticalsGlaxosmithkline pharmaceuticals internationalGeneral partnerManaging directorVice chairman

Cardior Pharmaceuticals: Cardior Appoints Cardiac Disease and RNA Drug Development Experts to its Scientific Advisory Board Supporting Pipeline Expansion in Both Large and Orphan Cardiac Indications

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the expansion of its Scientific Advisory

United kingdomCity ofUnited statesDavid crandallJohann bauersachsClaudia ulbrich barbara gaertner rupprechtPerry elliottBarry tichoCharlotte spitzGerasimos filippatosRahul agrawalKostenloser wertpapierhandelCommittee on clinical cardiovascular medicineUniversity college londonCommittee on acute heart failureUniversity of freiburg